5. uncertainty: will biotech produce profits?
“Thirty years ago it appeared as if biotech would
not only revolutionize healthcare, but also
radically improve the very process of R&D itself.
This hasn't happened.
Though some firms such as Amgen have created
dramatic breakthroughs, the overall industry
track record is poor—in aggregate, the sector
has lost money during this period, new research
shows.”